ABUS SCHEDULE 13G/A: SEC filing

Whitefort Capital Management and affiliated entities

Filed with the SEC on · accession 0000921895-26-003185

ABUS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Whitefort Capital Management and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.6% (2,451,033 shares) of Arbutus Biopharma's common stock as of September 30, 2026. The stock moved -1.0% by the first close after the filing.

Summary of the filing

Whitefort Capital Management and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.6% (2,451,033 shares) of Arbutus Biopharma's common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

Key details

Shares beneficially owned$2.5M
Percentage of outstanding shares beneficially ownedPCT 2
Reporting person / beneficial ownerWhitefort Capital Master Fund, LP
Investment manager / reporting personWhitefort Capital Management, LP
IssuerArbutus Biopharma Corp
Co-managing partner of whitefort capital management, lpDavid Salanic
Co-managing partner of whitefort capital management, lpJoseph Kaplan

How ABUS stock reacted

Close before

$4.09

Nov 13, 2026

First close after

-0.98%

$4.05

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ABUS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ABUS?

Click here

Frequently asked questions

What did ABUS file with the SEC on Nov 16, 2026?

ABUS filed a SCHEDULE 13G/A (SEC filing). Whitefort Capital Management and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.6% (2,451,033 shares) of Arbutus Biopharma's common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ABUS stock react to this filing?

ABUS closed at $4.09 before the filing and $4.05 on Nov 16, 2026 (-0.98%).

Other ABUS SEC filings

Get alerts when ABUS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days